Intranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants elicits increased vaginal immunoglobulin levels
- 13 December 2005
- Vol. 24 (13) , 2238-2247
- https://doi.org/10.1016/j.vaccine.2005.11.060
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- NALT- versus PEYER'S-patch-mediated mucosal immunityNature Reviews Immunology, 2004
- WT1 is a tumor‐associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cellsInternational Journal of Cancer, 2004
- Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8+ T cell population in different tissuesVaccine, 2003
- Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit BJournal of Virology, 2003
- Human Papillomavirus Type 16 L1 Capsomeres Induce L1-Specific Cytotoxic T Lymphocytes and Tumor Regression in C57BL/6 MiceJournal of Virology, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1Journal of Molecular Biology, 2001
- Regulation of the protein A-encoding gene in Staphylococcus aureusGene, 1992
- Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgeneNature, 1991
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985